Showing results (21-30 of 208) with videos related to
Sort By:
Pageof 21
Journal of Cell Communication and Signaling|May 24, 2019
Do drugs that target mTOR generate CCN2-mediated fibrogenic side effects?Andrew LeaskJournal of Cell Communication and Signaling|March 10, 2009
Death of a tumor: targeting CCN in pancreatic cancerAndrew LeaskJournal of Cell Communication and Signaling|August 25, 2009
Getting to the heart of the matter: CCN2 plays a role in cardiomyocyte hypertrophyAndrew LeaskJournal of Cell Communication and Signaling|December 2, 2011
MEK/ERK inhibitors: proof-of-concept studies in lung fibrosisAndrew LeaskSeminars in Cell & Developmental Biology|November 12, 2019
A centralized communication network: Recent insights into the role of the cancer associated fibroblast in the development of drug resistance in tumorsAndrew LeaskJournal of Cell Communication and Signaling|December 21, 2012
Sonic advance: CCN1 regulates sonic hedgehog in pancreatic cancerAndrew LeaskWound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|January 7, 2021
The hard problem: Mechanotransduction perpetuates the myofibroblast phenotype in scleroderma fibrosisAndrew LeaskThe Open Rheumatology Journal|July 18, 2012
Getting out of a sticky situation: targeting the myofibroblast in sclerodermaAndrew LeaskJournal of Cell Communication and Signaling|February 22, 2015
Yin and Yang revisited: CCN3 as an anti-fibrotic therapeutic?Andrew LeaskPageof 21